Maven's Asset-Light Margin Advantage
Maven Clinic
Maven’s margin advantage comes from selling coordination and guidance, not carrying the cost base of a clinic operator or the treatment pass through of an IVF benefits manager. It pays independent providers per consult, while most revenue now comes from employer platform fees, per member pricing, and benefits administration. That means more of each dollar stays with software, care navigation, and network management instead of rent, lab staff, or expensive procedures.
-
Maven started with $18 to $120 telehealth visits, but those are now a small revenue stream. The bigger business is annual employer contracts, $700 to $950 per member program fees, and $800 per enrollee for Maven Wallet. That mix makes provider payouts a variable service cost rather than the core revenue engine.
-
Kindbody follows the opposite model. It owns clinics and IVF labs, and has expanded through clinic buildout and acquisitions. That can produce strong gross margins, around 60%, because it captures more of the fertility journey, but it also requires more fixed cost, more operational complexity, and slower expansion than a contracted network.
-
Progyny shows a different margin drag. Its fertility benefits business runs at about 20% gross margin because IVF treatment dollars flow through the platform. Maven improves economics by steering some members to lower cost paths first, with 30% of fertility patients conceiving without IVF, and by avoiding ownership of the underlying care infrastructure.
The next step is using this model to take a larger share of family health spend without becoming a clinic chain. As Maven adds benefits administration, pediatrics, and menopause on top of the same provider network, it can keep layering higher value revenue onto a largely variable cost base, which is the clearest path to scaling margins with growth.